
    
      The primary objective of this study is to evaluate the effect of rosuvastatin 10-20 mg on
      carotid atherosclerosis progression in Chinese patients by evaluating the change in the
      percentage of volume of lipid rich necrotic core (LRNC) using high-resolution magnetic
      resonance imaging (MRI) after 24-months treatment.
    
  